Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | RALGAPB | Human | (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of RALGAPB protein | CTD | PMID:31195006 | RALGAPB | Human | 17alpha-ethynylestradiol | increases expression | ISO | Ralgapb (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of RALGAPB mRNA | CTD | PMID:29097150 | RALGAPB | Human | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31675489 | RALGAPB | Human | 3,3',5,5'-tetrabromobisphenol A | decreases expression | EXP | | 6480464 | tetrabromobisphenol A results in decreased expression of RALGAPB protein | CTD | PMID:31675489 | RALGAPB | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of RALGAPB gene | CTD | PMID:27153756 | RALGAPB | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of RALGAPB mRNA | CTD | PMID:24449571 | RALGAPB | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to RALGAPB mRNA] | CTD | PMID:32406909 | RALGAPB | Human | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of RALGAPB mRNA | CTD | PMID:22378314 | RALGAPB | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of RALGAPB mRNA | CTD | PMID:21632981 | RALGAPB | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of RALGAPB promoter | CTD | PMID:27901495 | RALGAPB | Human | benzo[a]pyrene diol epoxide I | increases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:26238291 | RALGAPB | Human | bisphenol A | increases methylation | ISO | Ralgapb (Mus musculus) | 6480464 | bisphenol A results in increased methylation of RALGAPB promoter | CTD | PMID:27312807 | RALGAPB | Human | bisphenol A | decreases expression | ISO | Ralgapb (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of RALGAPB mRNA | CTD | PMID:34947998 | RALGAPB | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RALGAPB mRNA | CTD | PMID:29275510 | RALGAPB | Human | bisphenol A | increases expression | ISO | Ralgapb (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of RALGAPB mRNA | CTD | PMID:29097150 | RALGAPB | Human | bisphenol A | increases methylation | ISO | Ralgapb (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of RALGAPB gene | CTD | PMID:28505145 | RALGAPB | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of RALGAPB gene | CTD | PMID:31601247 | RALGAPB | Human | caffeine | decreases expression | EXP | | 6480464 | Caffeine results in decreased expression of RALGAPB protein | CTD | PMID:31195006 | RALGAPB | Human | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of RALGAPB protein | CTD | PMID:35688186 | RALGAPB | Human | carbon nanotube | decreases expression | ISO | Ralgapb (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of RALGAPB mRNA | CTD | PMID:25554681 | RALGAPB | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of RALGAPB mRNA | CTD | PMID:27594783 | RALGAPB | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of RALGAPB mRNA | CTD | PMID:27392435 | RALGAPB | Human | coumarin | increases phosphorylation | EXP | | 6480464 | coumarin results in increased phosphorylation of RALGAPB protein | CTD | PMID:35688186 | RALGAPB | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of RALGAPB mRNA | CTD | PMID:37042841 | RALGAPB | Human | ethanol | affects splicing | ISO | Ralgapb (Mus musculus) | 6480464 | Ethanol affects the splicing of RALGAPB mRNA | CTD | PMID:30319688 | RALGAPB | Human | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of RALGAPB mRNA | CTD | PMID:23649840 | RALGAPB | Human | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of RALGAPB mRNA | CTD | PMID:23649840 | RALGAPB | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of RALGAPB protein | CTD | PMID:37730182 | RALGAPB | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of RALGAPB gene | CTD | PMID:31601247 | RALGAPB | Human | maneb | multiple interactions | ISO | Ralgapb (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of RALGAPB mRNA | CTD | PMID:36117858 | RALGAPB | Human | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of RALGAPB mRNA | CTD | PMID:24449571 | RALGAPB | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of RALGAPB mRNA | CTD | PMID:23649840 | RALGAPB | Human | oxaliplatin | multiple interactions | ISO | Ralgapb (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RALGAPB mRNA | CTD | PMID:25729387 | RALGAPB | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RALGAPB mRNA | CTD | PMID:21420995 | RALGAPB | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RALGAPB mRNA | CTD | PMID:22230336 | RALGAPB | Human | paraquat | multiple interactions | ISO | Ralgapb (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of RALGAPB mRNA | CTD | PMID:36117858 | RALGAPB | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of RALGAPB mRNA | CTD | PMID:23557933 | RALGAPB | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of RALGAPB mRNA | CTD | PMID:21457566 and PMID:38568856 | RALGAPB | Human | sodium fluoride | increases expression | ISO | Ralgapb (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of RALGAPB mRNA | CTD | PMID:27862939 | RALGAPB | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of RALGAPB mRNA | CTD | PMID:31533062 | RALGAPB | Human | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of RALGAPB mRNA | CTD | PMID:31758290 | RALGAPB | Human | thiram | increases expression | EXP | | 6480464 | Thiram results in increased expression of RALGAPB mRNA | CTD | PMID:38568856 | RALGAPB | Human | titanium dioxide | increases expression | ISO | Ralgapb (Mus musculus) | 6480464 | titanium dioxide analog results in increased expression of RALGAPB mRNA | CTD | PMID:25111187 | RALGAPB | Human | titanium dioxide | increases methylation | ISO | Ralgapb (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of RALGAPB gene | CTD | PMID:35295148 | RALGAPB | Human | topotecan | multiple interactions | ISO | Ralgapb (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RALGAPB mRNA | CTD | PMID:25729387 | RALGAPB | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of RALGAPB mRNA | CTD | PMID:37042841 | RALGAPB | Human | tungsten | decreases expression | ISO | Ralgapb (Mus musculus) | 6480464 | Tungsten results in decreased expression of RALGAPB mRNA | CTD | PMID:30912803 | |